Belantamab mafodotin for the treatment of multiple myeloma.
Bo Wang, Chengnian Wu, Qi Zhong, Juan Ling, Zhuman Wu, Bing Yu, Xiaoyan Gao, Huilan Zeng, Donghua Yang
págs. 653-663
págs. 665-675
Naxitamab: a humanized anti-glycolipid disialoganglioside (anti-GD2) monoclonal antibody for treatment of neuroblastoma.
Leonora R. Slatnick, Antonio Jimeno, Lia Gore, Margaret E. Macy
págs. 677-688
Aflibercept, ranibizumab and bevacizumab upcoming biosimilars: a general overview.
Pietro Viola, Valeria Testa, Lorenzo Ferro Desideri, Luca Di Cello, C. Rutigliani, Aldo Vagge, Massimo Nicolò, Roberto Cian, Roberto Traverso
págs. 689-697
© 2001-2024 Fundación Dialnet · Todos los derechos reservados